| Autor: |
Kaste SC; Division of Diagnostic Imaging, Department of Radiological Sciences, St. Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105-2794, USA. sue.kaste@stjude.org, Rodriguez-Galindo C, McCarville ME, Shulkin BL |
| Jazyk: |
angličtina |
| Zdroj: |
Pediatric radiology [Pediatr Radiol] 2007 Jul; Vol. 37 (7), pp. 615-22. Date of Electronic Publication: 2007 May 22. |
| DOI: |
10.1007/s00247-007-0467-4 |
| Abstrakt: |
Our objective was to assess the utility of PET-CT in five pediatric patients with Langerhans cell histiocytosis (LCH) who underwent PET-CT imaging for clinical staging and determination of lesion activity at various stages of treatment and follow-up. PET-CT combines the anatomic detail of CT and the physiologic activity of (18)F-FDG imaging. We conclude that PET-CT information is clinically useful to evaluate disease activity and response to therapy and provides information that cannot be obtained from technetium 99m methylene diphosphonate bone scans or radiographs. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full text from SpringerLink